However, there is limited data on the relation between death and progressive coronary atherothrombosis. (crtonline.org)
This study sought to evaluate what proportion of death after coronary revascularization is related to documented progressive coronary atherothrombosis. (crtonline.org)
Documented progressive coronary atherothrombosis as the cause of death was defined as preceding coronary revascularization within 30 days before death or irreversible brain damage and/or proof of coronary thrombus by autopsy. (crtonline.org)
Dominant causes of cardiac death in post-discharge patients included heart failure (10.0%) and sudden cardiac death (9.1%), both without apparent relation with progressive coronary atherothrombosis. (crtonline.org)
Cardiac death after discharge was very infrequently related to documented progressive coronary atherothrombosis. (crtonline.org)
Frequent causes of cardiac death were heart failure or sudden cardiac arrest without progressive coronary atherothrombosis. (crtonline.org)
Therefore, we sought to explore the actual causes of death and their relation with progressive coronary atherothrombosis documented by coronary angiography or autopsy in a large Japanese observational database of patients undergoing first coronary revascularization. (crtonline.org)
Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis. (ox.ac.uk)
The aim of this consensus document is to review the evidence for the efficacy and safety of antiplatelet drugs, and to provide practicing cardiologists with an updated instrument to guide their choice of the most appropriate antiplatelet strategy for the individual patient presenting with different clinical manifestations of coronary atherothrombosis, in light of comorbidities and/or interventional procedures. (ox.ac.uk)
Atherosclerosis2
The knowledge of the biochemical characteristics of PMPs and the understanding of the mechanisms of their actions can lead to further consideration of the antiplatelet drugs' effect in atherothrombosis, and the development of new therapeutic interventions, aiming not only to reduce plaque but also to prevent atherosclerosis. (japt.gr)
However, recent studies have found that there is another unexpected contributor to the development of atherosclerosis and atherothrombosis (blood clot formation): inflammation caused by bacterial infection. (naturalnews.com)
Statins2
The contemporary medications for secondary prevention like statins and antithrombotic agents are targeting to delay the progression of atherothrombosis. (crtonline.org)
Is There a Negative Interaction Between Use of Beta-Blocker and Statins on Atherothrombosis Risk? (acc.org)
Risk6
There are non-Aboriginal inexplicable hours on buy Traditional and Novel Risk Factors in Atherothrombosis 2012. (i-te.de)
South Australia with their buy Traditional and Novel Risk Factors in Atherothrombosis 2012 and high subsection. (i-te.de)
For buy Traditional and Novel Risk Factors in Atherothrombosis 2012, the vehicle of the appearance of ten highly caused former limits Is so functional by stage from an entire pervasive. (i-te.de)
Atherothrombosis and high-risk plaque: Part I: Evolving concepts. (thieme-connect.com)
An analysis of patients from the Reduction of Atherothrombosis for Continued Health (REACH) Registry was performed to evaluate the increase in cardiovascular risk associated with increasing numbers of enrichment criteria. (thrombosisadviser.com)
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? (bmj.com)
Agents1
Anti-atherothrombotic agents could at least theoretically prevent death caused by progression of atherothrombosis, but most likely could not prevent death unrelated to it. (crtonline.org)
Role1
Their role in the primary prevention of atherothrombosis remains controversial because of the uncertain balance of the potential benefits and risks when combined with other preventive strategies. (ox.ac.uk)
Patients1
Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry. (duke.edu)
Mechanisms of atherothrombosis1
Increased levels of platelet activation and subsequent residence near the plaque highlight the mechanisms of atherothrombosis. (bham.ac.uk)
Coronary Artery1
He has published more than 900 scientific articles in international medical journals, and two of the most prestigious books devoted to clinical cardiology and research: The Heart and Atherothrombosis and Coronary Artery Disease. (cnic.es)
Cardiovascular disease1
Background: Hyperhomocysteinemia may constitute an independent risk factor for cardiovascular disease and may promote atherothrombosis. (erdogan.edu.tr)
Antiplatelet2
Moreover, information on the efficacy and safety of antiplatelet drugs in the treatment and prevention of atherothrombosis is provided by collaborative meta-analyses of 287 secondary prevention trials and 6 primary prevention trials. (medscape.com)
The present document intends to provide practicing physicians with an updated instrument to guide their choice of the most suitable antiplatelet strategy for the individual patient at risk, or with different clinical manifestations, of atherothrombosis. (medscape.com)
Pathogenesis1
The endothelium regulates vascular homeostasis, and endothelial dysfunction is a proximate event in the pathogenesis of atherothrombosis. (nih.gov)
Clinical1
On the methodological point of view, the epidemiological implementation of research tools which explore the causal link between the cardiometabolic risk factors and the clinical appearances of the atherothrombosis is facilitated by the "captive" character of the population. (univ-reunion.fr)
Diabetes1
In comparison with in metropolitan France, Reunion is characterized by a high prevalence of the diabetes and the obesity (REDIA study) and an important mortality attributed to atherothrombosis. (univ-reunion.fr)
Plaque1
Atherothrombosis and plaque heterology: different location or a unique disease? (mmu.ac.uk)
Arterial1
Formation of unstable plaques frequently results in atherothrombosis, the major cause for ischaemic stroke, myocardial infarction and peripheral arterial disease. (mmu.ac.uk)
Therapies1
In 17 collaborative projects, individualized therapies against atherothrombosis are developed with the help of new research approaches and artificial intelligence. (curatime.org)
Diseases2
By bringing together powerful players from science and industry with complementary skills , we are meeting the challenge of tailoring the treatment of atherothrombosis-related cardiovascular diseases . (curatime.org)
Psoriasis is one of the diseases associated with increased atherothrombosis. (erdogan.edu.tr)
Significantly1
We have recently prospectively tested this approach in a double-blind placebo controlled trial and found that antioxidant therapy with vitamin E significantly reduced atherothrombosis in Hp 2-2 DM individuals. (nih.gov)
Increase1
ALOX5, LPA, MMP9 and TPO gene polymorphisms increase atherothrombosis susceptibility in middle-aged Mexicans. (cdc.gov)
Association1
Cluster for atherothrombosis and individualized medicine - An association of various partners from academia and industry in the Rhine-Main-Palatinate region. (curatime.org)